SORG
Rachel Harber is an experienced Event Coordinator currently working at KLS Martin Group and SORG since August 2021. Previously, Rachel held various roles at Tom James Company from May 2018 to August 2021, including Professional Sales Representative, Sales Trainer, Shareholder, and Leader. Additionally, Rachel has a background in marketing and social media as a Marketing Manager and Consultant at PlayATL and experience in live event promotion at Live! at the Battery Atlanta. Earlier career roles include positions in customer service, teaching, and retail, culminating in a Bachelor of Business Administration with a focus on Marketing and Sales Management from Georgia Southern University, which was completed in May 2018.
Previous companies
This person is not in any teams
This person is not in any offices
SORG
SORG stands for Strasbourg Osteosynthesis Research Group. Since our foundation in 1989, we pursue to foster the scientific development at all levels by both experimental research and clinical studies, as well as publications and continuing medical education. Our major focus is the development of new techniques and improved instrumentation in the fields of CMF surgery. To achieve those goals, we established regional groups all over the world. SORG Europe and North America feature six different sections focused on different areas of oral and craniomaxillofacial surgery. These sections include: craniofacial & pediatric surgery; preprosthetic surgery, implants & anesthesia; orthognathic, cosmetic & sleep apnea; TMJ & pain; trauma; and reconstructive surgery/tumors. To be a part of SORG means: - to participate in a scientific and technical way - to develop and clinically evaluate new techniques, devices, and therapies for craniomaxillofacial diseases, injuries, disorders and related pathologies - to advance and to accomplish specified research projects - to develop and to improve quality controls for treatment standards to organize continuous education and training events - to evaluate and publish scientific studies and research results - to inform the public and specialized groups through evidence-based, neutral public relation campaigns about the advantages and disadvantages of treatment options for craniomaxillofacial diseases and disorders - to inform about the overall social importance of treating craniomaxillofacial and related diseases at national and international level - to support cooperation between local and international institutions involved in development research and treatment evaluation